Fundz

Who to call at 10x Genomics, Inc., and when

Fundz watches for the moments 10x Genomics, Inc. starts buying, and tells you who to reach.

  • An alert the day 10x Genomics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 10x Genomics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 10x Genomics, Inc.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

10x Genomics, Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

www.10xgenomics.com
Filed: Nov 14, 2025Pleasanton, CaliforniaCIK: 0001770787Biotechnology
Full company profileView on SEC.gov

2 executive changes at 10x Genomics in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

10x Genomics announced that Chief Legal Officer Eric S. Whitaker will retire effective January 1, 2026, moving to a reduced-pay Strategic Counsel role, and that Dr. Randy Wu, its current VP of Intellectual Property and Litigation, will succeed him as General Counsel and Secretary on the same date. The change is an orderly, planned internal succession that keeps legal continuity in place.

Key Takeaways

Eric S. Whitaker, who served as Chief Legal Officer for more than eight years, will retire effective January 1, 2026, and remain an employee in a reduced-compensation Strategic Counsel role.

Dr. Randy Wu, who joined 10x Genomics in August 2016 and currently leads intellectual property and litigation, will become General Counsel and Secretary effective January 1, 2026.

2 more takeaways

Filing Overview

Form Type8-K
Filing DateNov 14, 2025
Item5.02
CategoryExecutive Change
CIK0001770787
Accession #0001628280-25-052154
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
leadership transitionexecutive departureexecutive hire

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

10x Genomics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.